Article Details
Retrieved on: 2021-07-02 14:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The focus of the deal is two clinical-stage monoclonal antibodies – AL001 and AL101 – that are designed to bolster progranulin (PGRN) levels. PGRN ...
Article found on: www.pmlive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here